Patents by Inventor Vernon A. Norviel
Vernon A. Norviel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11938150Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: GrantFiled: January 10, 2023Date of Patent: March 26, 2024Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Vernon A. Norviel, Michael S. McGrath
-
Patent number: 11938148Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: GrantFiled: January 10, 2023Date of Patent: March 26, 2024Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Vernon A. Norviel, Michael S. McGrath
-
Patent number: 11938147Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: GrantFiled: August 30, 2022Date of Patent: March 26, 2024Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Vernon A. Norviel, Michael S. McGrath
-
Patent number: 11938149Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: GrantFiled: January 10, 2023Date of Patent: March 26, 2024Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Vernon A. Norviel, Michael S. McGrath
-
Publication number: 20230218662Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: ApplicationFiled: January 10, 2023Publication date: July 13, 2023Inventors: Vernon A. NORVIEL, Michael S. MCGRATH
-
Publication number: 20230190789Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: ApplicationFiled: January 10, 2023Publication date: June 22, 2023Inventors: Vernon A. NORVIEL, Michael S. MCGRATH
-
Publication number: 20230181629Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: ApplicationFiled: August 30, 2022Publication date: June 15, 2023Inventors: Vernon A. NORVIEL, Michael S. MCGRATH
-
Publication number: 20230172974Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: ApplicationFiled: January 10, 2023Publication date: June 8, 2023Inventors: Vernon A. NORVIEL, Michael S. MCGRATH
-
Publication number: 20190060359Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.Type: ApplicationFiled: November 1, 2016Publication date: February 28, 2019Inventors: Vernon A. NORVIEL, Michael S. McGRATH
-
Publication number: 20100113295Abstract: The present invention discloses methods for combining data on genetic variations and phenotypes of individuals to predict a phenotype-of-interest. The present invention also discloses kits that can be used to determine if an individual has or does not have a phenotype-of-interest. The kit can include at least one diagnostic tool and written instructions.Type: ApplicationFiled: November 2, 2009Publication date: May 6, 2010Inventor: Vernon A. Norviel
-
Publication number: 20060166224Abstract: The present invention discloses methods for combining data on genetic variations and phenotypes of individuals to predict a phenotype-of-interest. The present invention also discloses kits that can be used to determine if an individual has or does not have a phenotype-of-interest. The kit can include at least one diagnostic tool and written instructions.Type: ApplicationFiled: January 24, 2005Publication date: July 27, 2006Inventor: Vernon Norviel
-
Publication number: 20050282156Abstract: Methods for concurrently processing multiple biological chip assays by providing a biological chip plate comprising a plurality of test wells, each test well having a biological chip having a molecular probe array; introducing samples into the test wells, subjecting the biological chip plate to manipulation by a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes; and subjecting the biological chip plate to a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes.Type: ApplicationFiled: July 1, 2005Publication date: December 22, 2005Applicant: Affymetrix, INC.Inventors: Richard Rava, Stephen Fodor, Mark Trulson, Vernon Norviel
-
Publication number: 20050181403Abstract: Methods for concurrently processing multiple biological chip assays by providing a biological chip plate comprising a plurality of test wells, each test well having a biological chip having a molecular probe array; introducing samples into the test wells, subjecting the biological chip plate to manipulation by a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes; and subjecting the biological chip plate to a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes.Type: ApplicationFiled: January 26, 2005Publication date: August 18, 2005Applicant: Affymetrix, INC.Inventors: Richard Rava, Stephen Fodor, Mark Trulson, Vernon Norviel
-
Publication number: 20050123907Abstract: Methods for concurrently processing multiple biological chip assays by providing a biological chip plate comprising a plurality of test wells, each test well having a biological chip having a molecular probe array; introducing samples into the test wells; subjecting the biological chip plate to manipulation by a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes; and subjecting the biological chip plate to a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes.Type: ApplicationFiled: November 24, 2004Publication date: June 9, 2005Applicant: Affymetrix, INC.Inventors: Richard Rava, Stephen Fodor, Mark Trulson, Vernon Norviel
-
Publication number: 20050042628Abstract: Methods for concurrently processing multiple biological chip assays by providing a biological chip plate comprising a plurality of test wells, each test well having a biological chip having a molecular probe array; introducing samples into the test wells; subjecting the biological chip plate to manipulation by a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes; and subjecting the biological chip plate to a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes.Type: ApplicationFiled: March 5, 2004Publication date: February 24, 2005Applicant: Affymetrix, Inc.Inventors: Richard Rava, Stephen Fodor, Mark Trulson, Vernon Norviel
-
Publication number: 20050009078Abstract: Systems, methods, and computer program products are described that process inquiries or orders regarding purchase of biological devices, substances, or related reagents. In some implementations, a user selects probe-set identifiers that identify microarray probe sets capable of enabling detection of biological molecules. Corresponding genes or EST's are identified and are correlated with related product data, which is provided to the user. Further, the user may select products for purchase based on the product data. If so, the user's account may be adjusted based on the purchase order. In the same or other implementations, a local genomic database is periodically updated. In response to a user selection of probe-set identifiers, data related to corresponding genes or EST's is provided to the user from the local genomic database.Type: ApplicationFiled: July 30, 2004Publication date: January 13, 2005Applicant: Affymetrix, INC.Inventors: David Craford, Vernon Norviel
-
Publication number: 20050004768Abstract: Systems, methods, and computer program products are described that process inquiries or orders regarding purchase of biological devices, substances, or related reagents. In some implementations, a user selects probe-set identifiers that identify microarray probe sets capable of enabling detection of biological molecules. Corresponding genes or EST's are identified and are correlated with related product data, which is provided to the user. Further, the user may select products for purchase based on the product data. If so, the user's account may be adjusted based on the purchase order. In the same or other implementations, a local genomic database is periodically updated. In response to a user selection of probe-set identifiers, data related to corresponding genes or EST's is provided to the user from the local genomic database.Type: ApplicationFiled: July 30, 2004Publication date: January 6, 2005Applicant: Affymetrix, INC.Inventors: David Craford, Vernon Norviel
-
Patent number: 6720149Abstract: Methods for concurrently processing multiple biological chip assays by providing a biological chip plate comprising a plurality of test wells, each test well having a biological chip having a molecular probe array; introducing samples into the test wells; subjecting the biological chip plate to manipulation by a fluid handling device that automatically performs steps to carry out reactions between target molecules in the samples and probes; and subjecting the biological chip plate to a biological chip plate reader that interrogates the probe arrays to detect any reactions between target molecules and probes.Type: GrantFiled: May 28, 2002Date of Patent: April 13, 2004Assignee: Affymetrix, Inc.Inventors: Richard P. Rava, Stephen P. A. Fodor, Mark Trulson, Vernon A. Norviel
-
Publication number: 20030097222Abstract: Systems, methods, and computer program products are described that process inquiries or orders regarding purchase of biological devices, substances, or related reagents. In some implementations, a user selects probe-set identifiers that identify microarray probe sets capable of enabling detection of biological molecules. Corresponding genes or EST's are identified and are correlated with related product data, which is provided to the user. Further, the user may select products for purchase based on the product data. If so, the user's account may be adjusted based on the purchase order. In the same or other implementations, a local genomic database is periodically updated. In response to a user selection of probe-set identifiers, data related to corresponding genes or EST's is provided to the user from the local genomic database.Type: ApplicationFiled: July 17, 2002Publication date: May 22, 2003Inventors: David M. Craford, Vernon A. Norviel